A surge of cardiac troponins appeared to be the norm even after uneventful coronary artery bypass graft (CABG) surgery, a ...

The FDA has granted a priority review to the supplemental Biologics License Application for enfortumab/pembrolizumab to all ...

At this year's American Society of Regional Anesthesia and Pain Medicine (ASRA) annual meeting, researchers at Hospital for Special Surgery (HSS) presented two studies focused on glucagon-like peptide ...

Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") and Pfizer Inc. (NYSE: PFE) announced that the U.S. Food and Drug Administration (FDA) accepted for Priority Review a ...

Please provide your email address to receive an email when new articles are posted on . Compared with placebo, tranexamic acid was linked with reduced perioperative blood loss and transfusions for ...

The KEYNOTE-671 trial showed a 71% 36-month overall survival rate with perioperative Keytruda, compared to 64% with placebo. FDA approvals for Keytruda, Imfinzi, and Opdivo in perioperative settings ...

Please provide your email address to receive an email when new articles are posted on . Smilowitz and Berger reviewed studies published between January 1, 1949 and January 27, 2020 to find available ...

Occipital meningomyeloceles are rare and challenging conditions for the anaesthesiologist, mainly because of the difficulty ...

A pain-informed model identified risk factors for clinically significant nausea in patients undergoing metabolic bariatric surgery.

Surgical and perioperative management approaches for orbital decompression used to treat thyroid-associated orbitopathy—also known as thyroid eye disease or Graves’ ophthalmopathy—vary widely by ...